Recommended Dosing for Nasonex (Mometasone Furoate)
Age-Specific Dosing Guidelines
- For adults and children 12 years and older, the American Academy of Otolaryngology-Head and Neck Surgery recommends 2 sprays per nostril once daily, with a total daily dose of 200 μg 1, 2
- For children 2-11 years old, the American Academy of Otolaryngology-Head and Neck Surgery recommends 1 spray per nostril once daily, with a total daily dose of 100 μg 1, 2
- For adults 18 years and older with nasal polyps, the American Academy of Otolaryngology-Head and Neck Surgery recommends 2 sprays per nostril twice daily, with a total daily dose of 400 μg 1, 2
Clinical Efficacy
- Mometasone furoate nasal spray is effective for both seasonal and perennial allergic rhinitis, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Safety Profile and Side Effects
- Common side effects of mometasone furoate nasal spray include headache, viral infection, pharyngitis, epistaxis (nosebleeds), and cough, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
- The American Academy of Otolaryngology-Head and Neck Surgery states that mometasone furoate nasal spray is contraindicated in patients with a history of hypersensitivity to the medication or its components 1, 2
Special Considerations
- For optimal results, the Praxis Medical Insights guideline recommends using Nasonex regularly rather than as-needed to maintain symptom control 3
- The Praxis Medical Insights guideline notes that the onset of action of Nasonex may be delayed, approximately 12 hours, with maximal efficacy reached in days to weeks 3
Nasonex Dosing Frequency for Nasal Polyps
Clinical Evidence
- Clinical trials in post-viral rhinosinusitis demonstrated that mometasone furoate 200 μg twice daily produced significantly greater symptom improvements compared to once-daily dosing, which is relevant to the treatment of nasal polyps 4
- The twice-daily dosing for nasal polyps reflects the more severe inflammatory burden in this condition, as supported by clinical evidence from Rhinology 4